Viatris has announced numerous updates and achievements. The company has reported its second quarter financial results for 2024 and confirmed the third quarter reports will be released on November 7, 2024. Additionally, Viatris declared its second quarter 2024 dividend. Notably, Viatris has executed all earlier declared divestitures with the conclusion of its over-the-counter business divestiture. The Q2 earnings of Viatris exceeded estimates. The U.S. Department of Justice has informed Viatris that it has ceased regarding Mylan as a subject in a generic drug industry antitrust investigation. Viatris's Q1 earnings and sales missed the estimated results causing a drop in the stock. However, Viatris's Q2 earnings are anticipated to be strong, supporting upcoming bullish tendencies. The company has been named to TIME’s World’s Most Sustainable Companies 2024 List. Finally, the Q1 earnings for 2024 aligned with EPS estimates amid strategic shifts.
Viatris VTRS News Analytics from Sun, 01 Oct 2023 07:00:00 GMT to Thu, 19 Sep 2024 17:25:00 GMT -
Rating 8
- Innovation 4
- Information 7
- Rumor -6
